Go Deep
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,203 | -25.1 | 2.35 | 0.00 | 4,891.20 |
| Oct 2026 | 21,250 | -24.7 | 2.31 | 0.00 | 4,814.79 |
| Oct 2026 | 21,027 | -26.8 | 2.47 | 0.00 | 5,147.84 |
| Oct 2026 | 21,215 | -25.0 | 2.33 | 0.00 | 4,858.88 |
| Oct 2026 | 21,059 | -26.3 | 2.44 | 0.00 | 5,103.02 |
| Oct 2026 | 20,971 | -26.9 | 2.50 | 0.00 | 5,233.86 |
| Oct 2026 | 21,278 | -24.6 | 2.27 | 0.00 | 4,770.72 |
| Oct 2026 | 21,138 | -25.7 | 2.37 | 0.00 | 4,973.45 |
Bright Minds Biosciences Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -2,398,255.0 | -10,459,627.0 | -7,565,318.0 | -4,085,603.0 |
| EPS | -0.2 | -1.1 | -1.0 | — |
Bright Minds Biosciences Inc. Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -12,229,348.0 | -2,801,946.0 | -7,372,225.0 | -14,964,941.0 |
| EPS | -1.8 | -0.7 | -2.0 | -6.1 |
Bright Minds Biosciences Inc. Balance Sheet
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Total Assets | 84,421,539.0 | 6,104,602.0 | 6,879,072.0 | 12,086,984.0 |
| Total Liabilities | 2,376,616.0 | 568,259.0 | 280,856.0 | 1,544,472.0 |
| Total Equity | 82,044,923.0 | 5,536,343.0 | 6,598,216.0 | 10,542,512.0 |
Owes vs Owns
Bright Minds Biosciences Inc. owed C$0.01 for every C$1 it owned in Jun 2026, down from C$0.13 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.01× | 0.03× | 0.09× | 0.04× | 0.13× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bright Minds Biosciences Inc. Assets & Liabilities Breakdown (CAD millions)
What it owns — Sep 2025
Cash & short-term investments 98.2%Other assets 1.2%
How it's funded — Sep 2025
Payables 2.0%Other liabilities 0.6%Shareholders' equity 97.2%
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 82.9 | 5.7 | 6.7 | 11.6 |
| Receivables | 0.4 | 0.1 | 0.0 | 0.2 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.1 | 0.1 | 0.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.0 | 0.2 | 0.0 | 0.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.1 |
| Payables | 1.7 | 0.4 | 0.2 | 1.2 |
| Other liabilities | 0.5 | 0.0 | 0.0 | 0.2 |
| Shareholders' equity | 82.0 | 5.5 | 6.6 | 10.5 |
| Net tangible assets | 82.0 | 5.5 | 6.6 | 10.5 |
Bright Minds Biosciences Inc. Cash Flow
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Operating Activities | -8,691,619.0 | -1,850,186.0 | -7,024,265.0 | -13,587,116.0 |
| Financing Activities | 85,567,491.0 | 810,572.0 | 2,189,686.0 | 5,196,190.0 |